Literature DB >> 22247447

Host defenses against zygomycetes.

Emmanuel Roilides1, Dimitrios P Kontoyiannis, Thomas J Walsh.   

Abstract

Mucormycosis is a devastating disease and can occur in patients with a variety of risk factors, the most important of which are immunosuppression, anatomic barrier breakdown, iron overload, and hyperglycemia/acidosis. Similarly to what occurs with Aspergillus, the host stimulates an innate immune response against the challenging sporangiospores and invading hyphae of Zygomycetes. This article discusses the host defense to different Zygomycetes, its augmentation, and its subsequent impact on the outcome of mucormycosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22247447     DOI: 10.1093/cid/cir869

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  18 in total

1.  Pulmonary mucormycosis due to Lichtheimia ramosa in a patient with HIV infection.

Authors:  Murat Kutlu; Cağrı Ergin; Ferda Bir; Süleyha Hilmioğlu-Polat; Ramazan Gümral; Ceyda Necan; Ali Koçyiğit; Selda Sayın-Kutlu
Journal:  Mycopathologia       Date:  2014-06-13       Impact factor: 2.574

Review 2.  Role of microglia in fungal infections of the central nervous system.

Authors:  George W Koutsouras; Raddy L Ramos; Luis R Martinez
Journal:  Virulence       Date:  2016-11-18       Impact factor: 5.882

3.  Mucorales spores induce a proinflammatory cytokine response in human mononuclear phagocytes and harbor no rodlet hydrophobins.

Authors:  Sebastian Wurster; Vanessa Thielen; Philipp Weis; Paul Walther; Johannes Elias; Ana Maria Waaga-Gasser; Mariola Dragan; Thomas Dandekar; Hermann Einsele; Jürgen Löffler; Andrew J Ullmann
Journal:  Virulence       Date:  2017-08-08       Impact factor: 5.882

Review 4.  Challenges in the diagnosis and treatment of mucormycosis.

Authors:  A Skiada; C Lass-Floerl; N Klimko; A Ibrahim; E Roilides; G Petrikkos
Journal:  Med Mycol       Date:  2018-04-01       Impact factor: 4.076

5.  Rhino-orbital-cerebral mucormycosis.

Authors:  Maria N Gamaletsou; Nikolaos V Sipsas; Emmanuel Roilides; Thomas J Walsh
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

6.  Rhinoorbitocerebral Mucormycosis with Maggots in a Neglected Diabetic Patient.

Authors:  Vivek Kumar Pathak; Rohit Saxena; Sanjeev Awasthi; Sushil Gaur; Sunil Kumar Singh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-07-21

Review 7.  Biology, systematics, and clinical manifestations of Zygomycota infections.

Authors:  A Muszewska; J Pawłowska; P Krzyściak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-11       Impact factor: 3.267

8.  Impaired T cell responsiveness to interleukin-6 in hematological patients with invasive aspergillosis.

Authors:  Jose F Camargo; Alyajahan Bhimji; Deepali Kumar; Rupert Kaul; Rhea Pavan; Andre Schuh; Matthew Seftel; Jeffrey H Lipton; Vikas Gupta; Atul Humar; Shahid Husain
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

9.  Clinical features, diagnosis, and outcomes of rhino-orbito-cerebral mucormycosis- A retrospective analysis.

Authors:  A Abdollahi; T Shokohi; N Amirrajab; R Poormosa; A M Kasiri; S J Motahari; S M Ghoreyshi; S A Madani; M Nikkhah; M Ghasemi; L Vahedi Larijani; M Didehdar; Z Seifi; N Gholinejad; M Ilkit
Journal:  Curr Med Mycol       Date:  2016-12

10.  Mucormycosis: An opportunistic pathogen during COVID-19.

Authors:  Iyer Mahalaxmi; Kaavya Jayaramayya; Dhivya Venkatesan; Mohana Devi Subramaniam; Kaviyarasi Renu; Padmavathi Vijayakumar; Arul Narayanasamy; Abilash Valsala Gopalakrishnan; Nachimuthu Senthil Kumar; Palanisamy Sivaprakash; Krothapalli R S Sambasiva Rao; Balachandar Vellingiri
Journal:  Environ Res       Date:  2021-07-06       Impact factor: 6.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.